Review
Published on 31 Oct 2024
Mechanisms of endocrine resistance in hormone receptor-positive breast cancer
in Breast Cancer
Frontiers in Oncology
doi 10.3389/fonc.2024.1448687
- 8,853 views
- 13 citations
107 articles related to "Hormone Receptor Positive"
Articles
Review
Published on 15 Mar 2017
Clinical Implications of ESR1 Mutations in Hormone Receptor-Positive Advanced Breast Cancer
in Women's Cancer
Frontiers in Oncology
doi 10.3389/fonc.2017.00026
- 29,397 views
- 90 citations
Review
Published on 04 May 2018
Precision Medicine in Hormone Receptor-Positive Breast Cancer
in Cancer Endocrinology
Frontiers in Oncology
doi 10.3389/fonc.2018.00144
- 13,407 views
- 43 citations
Original Research
Published on 17 May 2021
The Prognosis of Single Hormone Receptor-Positive Breast Cancer Stratified by HER2 Status
in Women's Cancer
Frontiers in Oncology
doi 10.3389/fonc.2021.643956
- 14,374 views
- 32 citations
Review
Published on 11 Mar 2025
Application status and research progress of targeted therapy drugs for hormone receptor-positive breast cancer
in Precision Medicine
Frontiers in Medicine
doi 10.3389/fmed.2025.1513836
- 3,777 views
- 2 citations
Review
Published on 13 Oct 2023
The role of the tumor microenvironment in endocrine therapy resistance in hormone receptor-positive breast cancer
in Cancer Endocrinology
Frontiers in Endocrinology
doi 10.3389/fendo.2023.1261283
- 7,102 views
- 23 citations
Mini Review
Published on 03 Nov 2021
The Role of Ki67 in Evaluating Neoadjuvant Endocrine Therapy of Hormone Receptor-Positive Breast Cancer
in Cancer Endocrinology
Frontiers in Endocrinology
doi 10.3389/fendo.2021.687244
- 71,093 views
- 93 citations
Systematic Review
Published on 02 Feb 2023
Clinicopathologic characteristics and prognostic significance of HER2-low expression in patients with early breast cancer: A systematic review and meta-analysis
in Breast Cancer
Frontiers in Oncology
doi 10.3389/fonc.2023.1100332
- 4,426 views
- 15 citations
Original Research
Published on 27 Apr 2023
Construction and validation of a risk prediction model for aromatase inhibitor-associated bone loss
in Breast Cancer
Frontiers in Oncology
doi 10.3389/fonc.2023.1182792
- 3,065 views
- 1 citation
Review
Published on 06 Nov 2025
Mechanistic optimization of inavolisib combined with CDK4/6 inhibitors in the treatment of PIK3CA-mutated breast tumors
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2025.1693927
- 2,199 views
Original Research
Published on 28 Nov 2022
Circulating tumor DNA profile and its clinical significance in patients with hormone receptor-positive and HER2-negative mBC
in Cancer Endocrinology
Frontiers in Endocrinology
doi 10.3389/fendo.2022.1075830
- 4,519 views
- 5 citations
Original Research
Published on 15 Jan 2025
Adding capivasertib to fulvestrant in patients with hormone receptor-positive advanced breast cancer: a cost-effectiveness analysis
in Drugs Outcomes Research and Policies
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1495082
- 4,519 views
- 3 citations
Original Research
Published on 20 Oct 2022
Real world outcomes with alpelisib in metastatic hormone receptor-positive breast cancer patients: A single institution experience
in Breast Cancer
Frontiers in Oncology
doi 10.3389/fonc.2022.1012391
- 9,386 views
- 14 citations
Review
Published on 14 Sep 2021
Ovarian Function Suppression With Luteinizing Hormone-Releasing Hormone Agonists for the Treatment of Hormone Receptor-Positive Early Breast Cancer in Premenopausal Women
in Breast Cancer
Frontiers in Oncology
doi 10.3389/fonc.2021.700722
- 25,686 views
- 25 citations
Original Research
Published on 16 Jun 2020
Independent Prognostic Value of Intratumoral Heterogeneity and Immune Response Features by Automated Digital Immunohistochemistry Analysis in Early Hormone Receptor-Positive Breast Carcinoma
in Women's Cancer
Frontiers in Oncology
doi 10.3389/fonc.2020.00950
- 8,006 views
- 26 citations
Original Research
Published on 18 Sep 2020
Plasma-Based Longitudinal Evaluation of ESR1 Epigenetic Status in Hormone Receptor-Positive HER2-Negative Metastatic Breast Cancer
in Women's Cancer
Frontiers in Oncology
doi 10.3389/fonc.2020.550185
- 7,409 views
- 27 citations